[1]Lettersindrugdesignanddiscovery,2016,vol.13,p.968-981
118863-62-0
494194-50-2
333771-24-7
126651-85-2
3414-96-8
39751-84-3
170655-60-4 | 1-Butanethiol, 4,4,4-trifluoro- | AA0078G4 | MFCD20233341
386229-70-5 | Sucrose Hexasulfate, Potassium Salt | AA0078Y9 | MFCD00270079
364794-81-0 | 4-(2-Morpholinoethyl)phenylboronic acid, pinacol ester | AA0079LS | MFCD04440855
362-76-5 | 2',3'-O-Isopropylideneguanosine | AA007A4Q | MFCD00057081
112496-59-0 | 7-Methoxytryptamine, HCl | AA007APY | MFCD01074512
107047-29-0 | 2,4-Dichloro-6-(trifluoromethyl)phenylhydrazine | AA007B9L | MFCD00174090
34775-04-7 | Ethyl 4-chloro-2-(pyridin-3-yl)pyrimidine-5-carboxylate | AA007BR0 | MFCD10699219
37013-86-8 | 1H-Pyrrole-2-carboxylic acid, 4-acetyl-3-ethyl-5-methyl-, ethyl ester | AA007CDL | MFCD00034388
108318-78-1 | 1-tert-butyl-4-propoxybenzene | AA007CZR | MFCD06277649
16681-77-9 | 1H-Tetrazole, 1-methyl- | AA007DIL | MFCD00129972